Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells.
Sandra MuntiónSilvia PreciadoElena Sánchez-LuisLuis CorcheteMaría Díez-CampeloLika OsuguiGerardo-Javier Martí-ChillónMaría-Belén VidrialesAlmudena Navarro-BailónJavier De Las RivasFermin M Sanchez-GuijoPublished in: Therapeutic advances in hematology (2022)
Our findings support the use of EP in cases where hematopoiesis is defective, despite its well-known direct effects on hematopoietic cells. Our findings suggest that further studies on the effects of EP on MSCs from patients with aplastic anemia are warranted.